Global Alzheimer’s disease market to reach $19.3 bn in 8MM by 2033 GlobalData Jan 14, 2025 GlobalData’s latest report reveals that, by 2033, DMTs are expected to dominate the global AD market, contributing 73.5 per cent…
NICE rejects second Alzheimer’s drug but opportunity remains for decision change: GlobalData EP News Bureau Oct 25, 2024 NICE's rejection of Kisunla raises cost-effectiveness concerns but future approval remains possible pending further evidence
